<DOC>
	<DOCNO>NCT02969395</DOCNO>
	<brief_summary>The purpose study evaluate product performance Magnetic Resonance ( MR ) Conditional Cardiac Implantable Electronic Devices ( CIED ) follow 3 tesla ( 3T ) MRI exposure . This achieve evaluating change pace capture threshold ( PCT ) measurement follow 3T MRI scan exposure . This study require FDA condition approval 3T MRI compatible label applicable CIED system . This study conduct within Medtronic 's post-market surveillance platform , Product Surveillance Registry ( PSR ) .</brief_summary>
	<brief_title>3T MRI CIED Post-Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Subject legally authorize representative provide write authorization and/or consent per institution geographical requirement Subject intend implant within 30 day postimplant qualify Medtronic 3T MR Conditional CIED system Subject , inaccessible followup study site Subject exclusion criterion require local law ( Europe , Central Asia [ ECA ] ) Implant followup data , include adverse device effect system modification implant time enrollment unavailable</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>3T</keyword>
	<keyword>Magnetic Resonance Imaging ( MRI )</keyword>
	<keyword>Implantable Cardioverter Defibrillator ( ICD )</keyword>
	<keyword>Implantable Pulse Generator ( IPG )</keyword>
	<keyword>Cardiac Resynchronization Therapy ( CRT )</keyword>
	<keyword>Cardiac Implantable Electronic Device ( CIED )</keyword>
</DOC>